Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)

Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
multiple-myeloma
multiple myeloma in relapse, multiple myeloma, multiple myeloma of bone, multiple myeloma with failed remission, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1033528
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.